Clinical trials
Recruiting Phase 3 Carcinoma, Ovarian Epithelial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Daiichi Sankyo | 1 |
| Ente Ospedaliero Ospedali Galliera | 1 |
| Imunon | 1 |
| Japanese Gynecologic Oncology Group | 1 |
| National Cancer Center, Korea | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
| Women's Hospital School Of Medicine Zhejiang University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 10 |
| Fallopian Tube Neoplasms | 5 |
| Ovarian Neoplasms | 4 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.